STERIS Total Assets 2010-2022 | STE

STERIS total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • STERIS total assets for the quarter ending September 30, 2022 were $10.490B, a 10.75% decline year-over-year.
  • STERIS total assets for 2022 were $11.424B, a 73.76% increase from 2021.
  • STERIS total assets for 2021 were $6.574B, a 20.83% increase from 2020.
  • STERIS total assets for 2020 were $5.441B, a 7.25% increase from 2019.
STERIS Annual Total Assets
(Millions of US $)
2022 $11,424
2021 $6,574
2020 $5,441
2019 $5,073
2018 $5,200
2017 $4,924
2016 $5,346
2015 $2,097
2014 $1,887
2013 $1,761
2012 $1,406
2011 $1,427
2010 $1,238
2009 $1,217
STERIS Quarterly Total Assets
(Millions of US $)
2022-09-30 $10,490
2022-06-30 $11,188
2022-03-31 $11,424
2021-12-31 $11,690
2021-09-30 $11,752
2021-06-30 $12,101
2021-03-31 $6,574
2020-12-31 $6,581
2020-09-30 $5,493
2020-06-30 $5,364
2020-03-31 $5,441
2019-12-31 $5,336
2019-09-30 $5,186
2019-06-30 $5,230
2019-03-31 $5,073
2018-12-31 $5,006
2018-09-30 $5,021
2018-06-30 $5,052
2018-03-31 $5,200
2017-12-31 $5,157
2017-09-30 $5,120
2017-06-30 $5,056
2017-03-31 $4,924
2016-12-31 $4,887
2016-09-30 $5,211
2016-06-30 $5,293
2016-03-31 $5,346
2015-12-31 $5,350
2015-09-30 $2,309
2015-06-30 $2,181
2015-03-31 $2,097
2014-12-31 $2,028
2014-09-30 $2,027
2014-06-30 $2,052
2014-03-31 $1,887
2013-12-31 $1,778
2013-09-30 $1,789
2013-06-30 $1,774
2013-03-31 $1,761
2012-12-31 $1,765
2012-09-30 $1,633
2012-06-30 $1,403
2012-03-31 $1,406
2011-12-31 $1,376
2011-09-30 $1,372
2011-06-30 $1,417
2011-03-31 $1,427
2010-12-31 $1,352
2010-09-30 $1,294
2010-06-30 $1,266
2010-03-31 $1,238
2009-12-31 $1,296
2009-09-30 $1,263
2009-06-30 $1,215
2009-03-31 $1,217
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $19.157B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00